Press Releases Items Per Page 102550 Year None20222021202020192018201720162015201420132012201120102007 11.21.22 Syndax Announces Participation at Evercore ISI Annual HealthCONx Conference 11.03.22 Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update 11.03.22 Syndax Announces Positive Updates to Clinical Activity and Durable Remissions in Phase 1 Portion of AUGMENT-101 Trial of Revumenib in Patients with Acute Leukemias 10.27.22 Syndax to Announce Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 3, 2022 08.08.22 Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update 08.02.22 Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022 06.16.22 Syndax Pharmaceuticals Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) 06.13.22 Syndax Pharmaceuticals Announces Appointment of Keith A. Goldan as Chief Financial Officer 05.26.22 Syndax Announces Participation at Two Upcoming Investor Conferences 05.11.22 Syndax Announces Participation at Citi's Biopharma Virtual Co-Panel Day 05.09.22 Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update 05.02.22 Syndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022 Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Page 6 Page 7 Page 8 Page 9 … Next page next › Last page last »
11.03.22 Syndax Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Clinical and Business Update
11.03.22 Syndax Announces Positive Updates to Clinical Activity and Durable Remissions in Phase 1 Portion of AUGMENT-101 Trial of Revumenib in Patients with Acute Leukemias
10.27.22 Syndax to Announce Third Quarter 2022 Financial Results and Host Conference Call and Webcast on November 3, 2022
08.08.22 Syndax Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Clinical and Business Update
08.02.22 Syndax to Announce Second Quarter 2022 Financial Results and Host Conference Call and Webcast on August 8, 2022
05.09.22 Syndax Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Clinical and Business Update
05.02.22 Syndax to Announce First Quarter 2022 Financial Results and Host Conference Call and Webcast on May 9, 2022
